SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitwise 10 Crypto Index ETF - Common Shares Of Beneficial Interest

Bitwise 10 Crypto Index Fund

Bitwise 10 Crypto Index Fund is currently a focal point of intense community debate, primarily driven by a dominant bearish narrative forecasting a severe 'crypto winter' and Bitcoin plummeting to $20,000 by late 2026, based on historical 4-year cycles. Conversely, some investors highlight BITW's significant discount to its Net Asset Value and its ongoing efforts to convert to an ETP structure as potential catalysts for future gains, amidst widespread frustration over its market performance.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is currently trending due to recent exploration results announcing the discovery of the highest-grade silver in its Vortex system, sparking renewed interest in its Nevada gold and silver assets. This news, coupled with strong broader market demand for precious metals in industrial applications, has fueled community speculation about the company's long-term potential and the possibility of a significant market move, despite some ongoing debate regarding its production timeline and profitability.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to its strategic pivot into powering the booming AI data center sector, notably through a significant $1.5 billion agreement with Applied Digital and other recent contract wins. The community is actively discussing whether its proven energy generation expertise positions it as a key 'picks and shovels' play for massive power demands, though concerns about valuation and market manipulation persist amidst recent contract announcements.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is currently soaring after securing FDA approval for YARTEMLEA, a groundbreaking first-in-class therapy for transplant-associated thrombotic microangiopathy (TA-TMA), a previously untreatable and often fatal condition. This pivotal approval, combined with an existing multi-billion dollar licensing deal with Novo Nordisk and significant short interest, has ignited immense excitement among investors who anticipate substantial long-term growth and a potential short squeeze. The community is actively discussing the company's strong de-risked financial position and the drug's unique market position, with many seeing this as the start of a new era for Omeros.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending amid its plan to split into two independent companies, a move intended to sharpen focus and unlock shareholder value. This announcement has fueled a sharp debate among investors, with optimists highlighting its potential as an undervalued, high-dividend consumer staple poised for a turnaround, while skeptics point to historical underperformance and notable shareholder Warren Buffett's public disappointment as reasons for concern. The stock is drawing attention from those seeking defensive plays and long-term value in the consumer staples sector.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending due to the recent FDA approval of AQVESME for alpha- and beta-thalassemia, making it the only approved medicine for these rare blood disorders. This development has sparked a significant volume surge and positive community discussion around the drug's unique market position, though some historical concerns regarding prior trial results for a separate indication and management performance are also noted.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending following the FCC's decision to ban Chinese-made drones and the passage of the NDAA, which is expected to significantly boost spending on American defense technology. The community is actively debating the company's strong production capacity for its Black Widow drones and the promising outlook for its Blue Ops Unmanned Surface Vessels, while also expressing impatience for firm contract announcements and caution over past management communications.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is seeing intense conversation following Sanofi's agreement to acquire the company for $15.50 per share, an offer bolstering Sanofi's adult immunization portfolio with Dynavax's hepatitis B vaccine and shingles candidate. Community sentiment is largely mixed, with long-term investors expressing disappointment over the perceived undervaluation, contrasting with others who welcome the guaranteed exit amidst a significant volume surge. The acquisition has also spurred discussions about the board's fiduciary duties and the possibility of a competing bid.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending following its recent Q3 earnings, which highlighted improved financials and international market growth, alongside the debated non-inclusion of Vascepa on China's NRDL. Community sentiment is divided, with some investors expressing frustration over market valuation while others remain optimistic about ongoing legal developments, progress on a lymphatic release patent, and strategic positioning for a potential acquisition driven by the company's valuable cardiovascular asset.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending as investors keenly follow ongoing SEC filings and strategic advancements to launch its AI-driven CapForce fintech platform, signaling potential steps towards Nasdaq relisting. The community is actively discussing hopes for a significant surge stemming from this pivot to digital investment banking, though skepticism remains due to the company's history of reverse splits and low trading volume in its current OTC Expert Market status.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

GILD.TSX
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC

Feed

News

Sentiment

Fundamentals

Info

Latest GILD.TSX News

GILD.TSXGilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC